Last 12 months
Inside the activity.
43 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 9 | 0 |
| Jun 2026 | 14 | 0 |
| Jul 2026 | 11 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 6 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2025 Filed Dec 19, 2025 16:42 UTC |
Klompas Neil ADirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,750 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001213900-25-123636 · ownership.xml · derivative · entry 1 Klompas Neil A · CIK 0001761857 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,250 Underlying: Common shares · 1,750 shares Expires 2030-12-18 F1 · derivative.exercise_date: The options were granted on 12/19/2025 and will vest 100% on the one-year anniversary of the grant date (December 18, 2026) or immediately prior to the next Annual General Meeting, whichever is sooner. Read SEC document |
| December 19, 2025 Filed Dec 19, 2025 16:40 UTC |
Bathery John StevenDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,750 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001213900-25-123630 · ownership.xml · derivative · entry 1 Bathery John Steven · CIK 0002093653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,250 Underlying: Common shares · 1,750 shares Expires 2030-12-18 F1 · derivative.exercise_date: The options were granted on 12/19/2025 and will vest 100% on the one-year anniversary of the grant date (December 18, 2026) or immediately prior to the next Annual General Meeting, whichever is sooner. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 12:19 UTC |
ADAMS ERIC ADirector · President & CEO
|
OtherEmployee Stock Option (Expiration) · Derivative | 250 | $0.00 Strike: $1,397.97 | $0.00 |
DisclosureSEC source: 0001213900-25-122647 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,050 Underlying: Common shares · 250 shares Expires 2025-12-15 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00 Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 12:16 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
OtherEmployee Stock Option (Expiration) · Derivative | 70 | $0.00 Strike: $1,397.97 | $0.00 |
DisclosureSEC source: 0001213900-25-122641 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,280 Underlying: Common shares · 70 shares Expires 2025-12-15 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00 Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 12:20 UTC |
HULL ANDREWDirector
|
OtherEmployee Stock Option (Expiration) · Derivative | 14 | $0.00 Strike: $1,397.97 | $0.00 |
DisclosureSEC source: 0001213900-25-122649 · ownership.xml · derivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 961 Underlying: Common shares · 14 shares Expires 2025-12-15 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00 Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 12:17 UTC |
WOUDENBERG MICHAELChief Operating Officer
|
OtherEmployee Stock Option (Expiration) · Derivative | 60 | $0.00 Strike: $1,397.97 | $0.00 |
DisclosureSEC source: 0001213900-25-122645 · ownership.xml · derivative · entry 1 WOUDENBERG MICHAEL · CIK 0001817884 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,445 Underlying: Common shares · 60 shares Expires 2025-12-15 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00 Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 17:58 UTC |
Klompas Neil ADirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001213900-25-100720 · ownership.xml · derivative · entry 1 Klompas Neil A · CIK 0001761857 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500 Underlying: Common shares · 3,500 shares Expires 2030-10-16 F1 · derivative.exercise_date: (1) The options were granted on Oct 17, 2025 and will vest monthly, in arrears, as follows: (i) 98 stock options will vest on the 17th day of each month for 35 months, and (ii) 70 stock options will vest on Oct 17, 2025 (the three year anniversary of Grant date). Read SEC document |
| January 11, 2025 Filed Feb 3, 2025 08:49 UTC |
HULL ANDREWDirector
|
OtherEmployee Stock Option (Expiration) · Derivative | 2 | $0.00 Strike: $2,860.21 | $0.00 |
DisclosureSEC source: 0001213900-25-009136 · ownership.xml · derivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 975 Underlying: Common shares · 2 shares Expires 2025-01-11 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$4,125.00 using an exchange rate of C$1.4422 = $US1.00 Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 09:26 UTC |
Jagpal NettaChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111568 · ownership.xml · derivative · entry 1 Jagpal Netta · CIK 0002013468 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 Underlying: Common shares · 3,750 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month). F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 09:21 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,750 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111554 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,350 Underlying: Common shares · 2,750 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month). F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 09:20 UTC |
ADAMS ERIC ADirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111552 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,300 Underlying: Common shares · 6,250 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month). F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 09:17 UTC |
HULL ANDREWDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 550 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111543 · ownership.xml · derivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 977 Underlying: Common shares · 550 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner. F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 09:24 UTC |
WOUDENBERG MICHAELChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111563 · ownership.xml · derivative · entry 1 WOUDENBERG MICHAEL · CIK 0001817884 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,505 Underlying: Common shares · 3,750 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month). F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 09:18 UTC |
Baldasare Bryan TDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 550 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111548 · ownership.xml · derivative · entry 1 Baldasare Bryan T · CIK 0001761920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 975 Underlying: Common shares · 550 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner. F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 09:22 UTC |
Grove Janet PDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 550 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111558 · ownership.xml · derivative · entry 1 Grove Janet P · CIK 0001355675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 975 Underlying: Common shares · 550 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner. F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 14:28 UTC |
Johnson Shane AaronSr VP & General Manager
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111570 · ownership.xml · derivative · entry 1 Johnson Shane Aaron · CIK 0001889332 · Sr VP & General Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,900 Underlying: Common shares · 1,500 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month). F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 14:25 UTC |
Lemerond NicoleDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 550 | $0.00 Strike: $4.14 | $0.00 |
DisclosureSEC source: 0001213900-24-111566 · ownership.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 975 Underlying: Common shares · 550 shares Expires 2029-12-19 F1 · derivative.exercise_date: The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner. F2 · balance_after: On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 16:02 UTC |
MANCINI ALEXANDRA DIANE JANETConsultant
|
SaleCommon Stock | 240 | $0.18 | $42.31 |
DisclosureSEC source: 0001213900-24-064728 · ownership.xml · nonDerivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Consultant 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 27, 2024 Filed May 28, 2024 16:26 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
OtherEmployee Stock Option (Expiration) · Derivative | 545 | $0.00 Strike: $263.18 | $0.00 |
DisclosureSEC source: 0001213900-24-047095 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,000 Underlying: Common shares · 545 shares Expires 2024-05-27 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00 Read SEC document |
| May 27, 2024 Filed May 28, 2024 16:26 UTC |
ADAMS ERIC ADirector · President & CEO
|
OtherEmployee Stock Option (Expiration) · Derivative | 1,139 | $0.00 Strike: $263.18 | $0.00 |
DisclosureSEC source: 0001213900-24-047094 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,000 Underlying: Common shares · 1,139 shares Expires 2024-05-27 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00 Read SEC document |
| May 27, 2024 Filed May 28, 2024 16:26 UTC |
MANCINI ALEXANDRA DIANE JANETSr VP, Clinical Reg Affairs
|
OtherEmployee Stock Option (Expiration) · Derivative | 485 | $0.00 Strike: $263.18 | $0.00 |
DisclosureSEC source: 0001213900-24-047093 · ownership.xml · derivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Sr VP, Clinical Reg Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,000 Underlying: Common shares · 485 shares Expires 2024-05-27 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00 Read SEC document |
| May 27, 2024 Filed May 28, 2024 16:27 UTC |
WOUDENBERG MICHAELChief Operating Officer
|
OtherEmployee Stock Option (Expiration) · Derivative | 394 | $0.00 Strike: $263.18 | $0.00 |
DisclosureSEC source: 0001213900-24-047096 · ownership.xml · derivative · entry 1 WOUDENBERG MICHAEL · CIK 0001817884 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,100 Underlying: Common shares · 394 shares Expires 2024-05-27 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00 Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 15:20 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
OtherEmployee Stock Option (Expiration) · Derivative | 309 | $0.00 Strike: $364.72 | $0.00 |
DisclosureSEC source: 0001213900-24-020087 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,545 Underlying: Common shares · 309 shares Expires 2024-03-04 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$495 using an exchange rate of C$1.3572 = $US1.00 Read SEC document |
| February 21, 2024 Filed Feb 22, 2024 13:38 UTC |
HULL ANDREWDirector
|
PurchaseCommon Stock | 37,500 | $0.39 | $14,625.00 |
DisclosureSEC source: 0001213900-24-016026 · ownership.xml · nonDerivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,258 Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 14:58 UTC |
ADAMS ERIC ADirector · President & CEO
|
PurchaseCommon Stock | 41,600 | $0.36 | $14,921.92 |
DisclosureSEC source: 0001213900-24-015703 · ownership.xml · nonDerivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,959 Read SEC document |
| January 21, 2024 Filed Mar 5, 2024 15:20 UTC |
MANCINI ALEXANDRA DIANE JANETSr VP, Clinical Reg Affairs
|
OtherEmployee Stock Option (Expiration) · Derivative | 121 | $0.00 Strike: $312.73 | $0.00 |
DisclosureSEC source: 0001213900-24-020086 · ownership.xml · derivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Sr VP, Clinical Reg Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,485 Underlying: Common shares · 121 shares Expires 2024-01-21 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$420.75 using an exchange rate of C$1.3454 = $US1.00 Read SEC document |
| January 14, 2024 Filed Mar 5, 2024 15:20 UTC |
HULL ANDREWDirector
|
OtherEmployee Stock Option (Expiration) · Derivative | 42 | $0.00 Strike: $307.01 | $0.00 |
DisclosureSEC source: 0001213900-24-020088 · ownership.xml · derivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,542 Underlying: Common shares · 42 shares Expires 2024-01-14 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$412.50 using an exchange rate of C$1.3436 = $US1.00 Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 13:07 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098490 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common shares · 45,000 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month). Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 13:07 UTC |
ADAMS ERIC ADirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 136,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098489 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,139 Underlying: Common shares · 136,000 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month). Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 13:04 UTC |
MANCINI ALEXANDRA DIANE JANETSr VP, Clinical Reg Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098487 · ownership.xml · derivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Sr VP, Clinical Reg Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,606 Underlying: Common shares · 45,000 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month). Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 13:04 UTC |
HULL ANDREWDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,100 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098486 · ownership.xml · derivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,584 Underlying: Common shares · 7,100 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner. Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 13:09 UTC |
WOUDENBERG MICHAELChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098494 · ownership.xml · derivative · entry 1 WOUDENBERG MICHAEL · CIK 0001817884 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,494 Underlying: Common shares · 65,000 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month). Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 13:05 UTC |
Baldasare Bryan TDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,100 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098488 · ownership.xml · derivative · entry 1 Baldasare Bryan T · CIK 0001761920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common shares · 7,100 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner. Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 13:08 UTC |
Grove Janet PDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,100 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098491 · ownership.xml · derivative · entry 1 Grove Janet P · CIK 0001355675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common shares · 7,100 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner. Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 18:09 UTC |
Johnson Shane AaronSr VP & General Manager
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098497 · ownership.xml · derivative · entry 1 Johnson Shane Aaron · CIK 0001889332 · Sr VP & General Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Underlying: Common shares · 40,000 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month). Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 18:09 UTC |
Lemerond NicoleDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,100 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098495 · ownership.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common shares · 7,100 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner. Read SEC document |
| December 23, 2023 Filed Dec 26, 2023 18:08 UTC |
Tegge JonathanInterim CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001213900-23-098492 · ownership.xml · derivative · entry 1 Tegge Jonathan · CIK 0001755310 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,400 Underlying: Common shares · 30,000 shares Expires 2028-12-22 F1 · derivative.exercise_date: The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month). Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 09:02 UTC |
WOUDENBERG MICHAELChief Operating Officer
|
OtherEmployee Stock Option (Expiration) · Derivative | 848 | $0.00 Strike: $270.36 | $0.00 |
DisclosureSEC source: 0001213900-23-093299 · ownership.xml · derivative · entry 1 WOUDENBERG MICHAEL · CIK 0001817884 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,494 Underlying: Common shares · 848 shares Expires 2023-12-05 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$367.125 using an exchange rate of C$1.3579 = $US1.00 Read SEC document |
| August 31, 2023 Filed Aug 31, 2023 17:22 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
OtherEmployee Stock Option (Expiration) · Derivative | 327 | $0.00 Strike: $499.96 | $0.00 |
DisclosureSEC source: 0001213900-23-072856 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,854 Underlying: Common shares · 327 shares Expires 2023-08-31 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$676.50 using an exchange rate of C$1.3531 = $US1.00 Read SEC document |
| May 16, 2023 Filed May 16, 2023 18:00 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
OtherEmployee Stock Option (Expiration) · Derivative | 152 | $0.00 Strike: $623.93 | $0.00 |
DisclosureSEC source: 0001213900-23-040579 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,181 Underlying: Common shares · 152 shares Expires 2023-05-16 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00 Read SEC document |
| May 16, 2023 Filed May 16, 2023 17:58 UTC |
ADAMS ERIC ADirector · President & CEO
|
OtherEmployee Stock Option (Expiration) · Derivative | 1,818 | $0.00 Strike: $623.93 | $0.00 |
DisclosureSEC source: 0001213900-23-040577 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,139 Underlying: Common shares · 1,818 shares Expires 2023-05-16 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00 Read SEC document |
| May 16, 2023 Filed May 16, 2023 17:59 UTC |
MANCINI ALEXANDRA DIANE JANETSr VP, Clinical Reg Affairs
|
OtherEmployee Stock Option (Expiration) · Derivative | 485 | $0.00 Strike: $623.93 | $0.00 |
DisclosureSEC source: 0001213900-23-040578 · ownership.xml · derivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Sr VP, Clinical Reg Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,606 Underlying: Common shares · 485 shares Expires 2023-05-16 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 15:45 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
OtherEmployee Stock Option (Expiration) · Derivative | 545 | $0.00 Strike: $927.64 | $0.00 |
DisclosureSEC source: 0001213900-23-018869 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common shares · 545 shares Expires 2023-03-08 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 15:43 UTC |
ADAMS ERIC ADirector · President & CEO
|
OtherEmployee Stock Option (Expiration) · Derivative | 545 | $0.00 Strike: $927.64 | $0.00 |
DisclosureSEC source: 0001213900-23-018866 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,957 Underlying: Common shares · 545 shares Expires 2023-03-08 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 15:47 UTC |
MANCINI ALEXANDRA DIANE JANETSr VP, Clinical Reg Affairs
|
OtherEmployee Stock Option (Expiration) · Derivative | 61 | $0.00 Strike: $927.64 | $0.00 |
DisclosureSEC source: 0001213900-23-018871 · ownership.xml · derivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Sr VP, Clinical Reg Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,091 Underlying: Common shares · 61 shares Expires 2023-03-08 F1 · derivative.exercise_price: Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00 Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 17:03 UTC |
Li SarahVP Accounting & Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,600 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-22-080994 · ownership.xml · derivative · entry 1 Li Sarah · CIK 0001956288 · VP Accounting & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common shares · 3,600 shares Expires 2027-12-15 F1 · derivative.exercise_date: The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 16:49 UTC |
HSU ERIC CSr. VP, Pre-Clinical Res/Dev
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 4,200 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-22-080968 · ownership.xml · derivative · entry 1 HSU ERIC C · CIK 0001817867 · Sr. VP, Pre-Clinical Res/Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,878 Underlying: Common shares · 4,200 shares Expires 2027-12-15 F1 · derivative.exercise_date: The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant. F2 · balance_after: On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 16:50 UTC |
ADAMS ERIC ADirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-22-080967 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,502 Underlying: Common shares · 15,000 shares Expires 2027-12-15 F1 · derivative.exercise_date: The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant. F2 · balance_after: On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 16:47 UTC |
MANCINI ALEXANDRA DIANE JANETSr VP, Clinical Reg Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 4,200 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-22-080960 · ownership.xml · derivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Sr VP, Clinical Reg Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,152 Underlying: Common shares · 4,200 shares Expires 2027-12-15 F1 · derivative.exercise_date: The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant. F2 · balance_after: On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 16:51 UTC |
HULL ANDREWDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 840 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-22-080959 · ownership.xml · derivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,484 Underlying: Common shares · 840 shares Expires 2027-12-15 F1 · derivative.exercise_date: The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner. F2 · balance_after: On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.